ZimVie Inc. (ZIMV)
Oct 21, 2025 - ZIMV was delisted (reason: acquired by ARCHIMED)
18.99
0.00 (0.00%)
Inactive · Last trade price on Oct 17, 2025
ZimVie Revenue
ZimVie had revenue of $116.66M in the quarter ending June 30, 2025, a decrease of -0.13%. This brings the company's revenue in the last twelve months to $443.40M, down -2.20% year-over-year. In the year 2024, ZimVie had annual revenue of $449.75M, down -1.68%.
Revenue (ttm)
$443.40M
Revenue Growth
-2.20%
P/S Ratio
1.19
Revenue / Employee
$250,510
Employees
1,770
Market Cap
535.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 449.75M | -7.68M | -1.68% |
| Dec 31, 2023 | 457.43M | -5.86M | -1.26% |
| Dec 31, 2022 | 463.29M | -9.02M | -1.91% |
| Dec 31, 2021 | 472.31M | -440.12M | -48.24% |
| Dec 31, 2020 | 912.43M | -143.07M | -13.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionZIMV News
- 18 days ago - ZimVie Announces Completion of its Acquisition by ARCHIMED - GlobeNewsWire
- 4 weeks ago - ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED - GlobeNewsWire
- 7 weeks ago - ZIMVIE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ZimVie Inc. - ZIMV - Business Wire
- 3 months ago - ZimVie Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025 - GlobeNewsWire
- 3 months ago - ZimVie Announces Exclusive Distribution Agreement with Osstem Implant to Expand Premium Dental Implant Offering in China - GlobeNewsWire
- 3 months ago - ZimVie Announces Definitive Agreement to be Acquired by ARCHIMED for $19.00 Per Share in Cash - GlobeNewsWire
- 5 months ago - ZimVie: Screening Cheap (Rating Upgrade) - Seeking Alpha